WHO Countries Should Address Ephedrine Abuse Individually - Weider
This article was originally published in The Tan Sheet
The regulation of ephedrine-containing products by member states of the World Health Organization should be handled on a case-by-case basis consistent with reported abuse problems within each country, Weider Nutrition advises FDA in Feb. 10 comments.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC